Adicet Bio Ownership | Who Owns Adicet Bio?

Adicet Bio Ownership Summary

Adicet Bio is owned by 63.35% institutional investors, 2.76% insiders, and 33.90% retail investors. Orbimed advisors is the largest institutional shareholder, holding 12.60% of ACET shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.51% of its assets in Adicet Bio shares.

ACET Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Adicet Bio	63.35%	2.76%	33.90%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	11.45M	12.60%	$11.01M
Tang capital management	8.15M	8.97%	$7.84M
Ra capital management	7.54M	8.30%	$7.25M
Goldman sachs group	3.75M	4.13%	$3.61M
Vanguard group	3.21M	3.53%	$3.08M
Carlyle group	2.95M	3.25%	$2.84M
Aquilo capital management	2.53M	2.79%	$2.44M
Acadian asset management	2.00M	2.20%	$1.93M
Millennium management	1.81M	2.00%	$1.75M
Morgan stanley	1.12M	1.41%	$1.35M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aquilo capital management	2.53M	3.67%	$2.44M
Stonepine capital management	700.00K	0.54%	$673.40K
Tang capital management	8.15M	0.52%	$7.84M
Orbimed advisors	11.45M	0.23%	$11.01M
Dafna capital management	600.00K	0.15%	$577.20K
Caxton	17.49K	0.10%	$16.82K
Ra capital management	7.54M	0.10%	$7.25M
Johnson & johnson	364.47K	0.09%	$350.62K
Regeneron pharmaceuticals	968.18K	0.09%	$931.39K
Carlyle group	2.95M	0.07%	$2.84M

Top Buyers

Holder	Shares	% Assets	Change
Regeneron pharmaceuticals	968.18K	0.09%	968.18K
Norges bank	429.55K	0.00%	429.55K
Squarepoint ops	184.36K	0.00%	184.36K
Bridgeway capital management	1.03M	0.02%	175.00K
Ubs group	203.23K	-	161.63K

Top Sellers

Holder	Shares	% Assets	Change
Balyasny asset management	-	-	-6.18M
Morgan stanley	1.12M	0.00%	-2.95M
Blackrock	1.02M	-	-2.36M
Commodore capital lp	-	-	-1.37M
Rtw investments, lp	-	-	-1.05M

New Positions

Holder	Shares	% Assets	Change	Value
Regeneron pharmaceuticals	968.18K	0.09%	968.18K	$931.39K
Norges bank	429.55K	0.00%	429.55K	$413.23K
Virtu financial	30.61K	0.00%	30.61K	$29.00K
Macquarie group	2.69K	-	2.69K	$3.26K
Bnp paribas arbitrage, snc	894.00	-	894.00	$860.00

Sold Out

Holder	Change
Zurcher kantonalbank (zurich cantonalbank)	-2.00
Nelson, van denburg & campbell wealth management group	-7.00
Truvestments capital	-252.00
New york state common retirement fund	-467.00
Cwm	-782.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	63	-	57,546,909	1.50%	63	1.63%	21	-8.70%	22	10.00%
Sep 30, 2024	63	-27.59%	56,696,707	-11.34%	62	0.95%	24	-47.83%	20	-16.67%
Jun 30, 2024	87	-13.00%	63,950,934	-14.41%	80	0.91%	46	-35.21%	24	84.62%
Mar 31, 2024	100	26.58%	74,719,814	123.93%	94	1.57%	71	91.89%	13	-50.00%
Dec 31, 2023	79	-5.95%	33,367,571	-5.33%	77	1.15%	37	-15.91%	26	23.81%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.07M	2.51%	-
Vanguard US Total Market Shares ETF	2.07M	2.51%	-
Vanguard Institutional Extnd Mkt Idx Tr	1.08M	1.31%	-
Bridgeway Ultra-Small Company	810.30K	0.98%	150.00K
Fidelity Extended Market Index	338.99K	0.41%	-2.16K
A4Investments SICAV SIF ACCI IlanaA2EURH	325.00K	0.39%	35.00K
Fidelity Enhanced Small Cap ETF	242.49K	0.29%	-
Bridgeway Ultra-Small Company Market	216.30K	0.26%	25.00K
Goldman Sachs Small Cp Val Insghts Instl	171.19K	0.21%	171.19K
iShares Micro-Cap ETF	150.58K	0.18%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 05, 2024	Kauffman Michael	-	Sell	$8.44K
Jan 25, 2024	ORBIMED ADVISORS LLC		Buy	$2.50M
Jan 25, 2024	ORBIMED ADVISORS LLC		Buy	$4.42M
Jan 25, 2024	ORBIMED ADVISORS LLC		Buy	$581.28K
Jan 25, 2024	GORDON CARL L		Buy	$4.42M

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	1
2024 Q1	6	-
2023 Q4	1	-
2023 Q3	1	2

ACET Ownership FAQ

Who Owns Adicet Bio?

Adicet Bio shareholders are primarily institutional investors at 63.35%, followed by 2.76% insiders and 33.89% retail investors. The average institutional ownership in Adicet Bio's industry, Biotech Stocks , is 68.48%, which Adicet Bio falls below.

Who owns the most shares of Adicet Bio?

Adicet Bio’s largest shareholders are Orbimed advisors (11.45M shares, 12.60%), Tang capital management (8.15M shares, 8.97%), and Ra capital management (7.54M shares, 8.30%). Together, they hold 29.87% of Adicet Bio’s total shares outstanding.

Does Blackrock own Adicet Bio?

BlackRock is not among the top 10 institutional shareholders of Adicet Bio.

Who is Adicet Bio’s biggest shareholder by percentage of total assets invested?

Aquilo capital management is Adicet Bio’s biggest shareholder by percentage of total assets invested, with 3.67% of its assets in 2.53M Adicet Bio shares, valued at 2.44M$.

Who is the top mutual fund holder of Adicet Bio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Adicet Bio shares, with 2.51% of its total shares outstanding invested in 2.07M Adicet Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools